CTNNA1 Familial Expansion Study
Start Date
3/16/2021
Completion Date
1/1/2028
Summary
The goal of the CAFÉ Study is to determine the cancer risks associated with germline CTNNA1 loss-of-function variants.
Detailed Description
The CAFÉ Study aims to determine the degree to which loss-of-function variants in the CTNNA1 gene are associated with hereditary cancers, including gastric cancer, breast cancer, as well as other cancers that may be associated with this gene. By obtaining personal and family history information from individuals who carry a CTNNA1 loss-of-function variant and their family members, this study will aim to better define CTNNA1 associated cancer risks and determine whether there is a genotype/phenotype correlation for CTNNA1 loss-of-function variants. This information will be important for the future cancer risk management of individuals who carry a CTNNA1 loss-of-function variant.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Collection of personal and family history from CAFÉ Study participants
Conditions
Locations
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States